Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2012
11/20/2012CA2762042C Chimeric influenza virus-like particles comprising hemagglutinin
11/20/2012CA2633171C Antibodies against tumor-associated antigenic target (tat) polypeptides
11/20/2012CA2560278C Modified bouganin proteins, cytotoxins and methods and uses thereof
11/20/2012CA2482929C Tuberculin immunoadjuvant
11/20/2012CA2467365C Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions
11/20/2012CA2448796C Vaccine against the nile fever virus
11/20/2012CA2426679C Preventive or therapeutic agent for psoriasis comprising il-6 antagonist as active ingredient
11/20/2012CA2421580C Discrimination between gnrh-i and gnrh-ii
11/20/2012CA2380331C Multiple cytokine-antibody complexes
11/20/2012CA2343653C Recombinant newcastle disease virus rna expression systems and vaccines
11/20/2012CA2265915C Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
11/15/2012WO2012155055A2 Integrin-targeted imaging of inflammation in vascular remodeling
11/15/2012WO2012155053A1 Modified biotin-binding protein, fusion proteins thereof and applications
11/15/2012WO2012155049A1 Treatment of lung inflammation
11/15/2012WO2012155007A1 Multiple antigen presenting immunogenic composition, and methods and uses thereof
11/15/2012WO2012154999A1 Methods of treating or preventing cholesterol related disorders
11/15/2012WO2012154944A2 Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits
11/15/2012WO2012154861A2 Cancer treatments
11/15/2012WO2012154818A1 B-glucan compounds, compositions, and methods
11/15/2012WO2012154809A1 Compositions and methods for treating cancer
11/15/2012WO2012154759A2 Genetically engineered growth factor variants
11/15/2012WO2012154587A2 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
11/15/2012WO2012154530A1 Recombinant immunotoxin targeting mesothelin
11/15/2012WO2012154480A1 c-KIT ANTIBODIES AND USES THEREOF
11/15/2012WO2012154311A2 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing
11/15/2012WO2012154203A2 Filovirus fusion proteins and their uses
11/15/2012WO2012154202A1 Recombinant subunit dengue virus vaccine
11/15/2012WO2012154199A1 Soluble recombinant plasmodium falciparum circumsporozoite protein
11/15/2012WO2012154121A1 Protein f - a novel haemophilus influenzae adhesin with laminin and vitronectin binding properties
11/15/2012WO2012154072A1 Exopolysaccharide of shigella sonnei bacteria, method for producing same, vaccine and pharmaceutical composition containing same
11/15/2012WO2012153707A1 Antibody specifically recognising transferrin receptor
11/15/2012WO2012153620A1 Drug, functional food, method for stabilizing target protein, fused protein, nucleic acid, and recombinant
11/15/2012WO2012153193A2 Protein-active agent conjugates and method for preparing the same
11/15/2012WO2012153160A1 Recombinant vaccine against prrs in a viral vector
11/15/2012WO2012152792A1 Molecule for treating an inflammatory disorder
11/15/2012WO2012152709A1 Hydrophobic preparations
11/15/2012WO2012152644A1 Production of dense bodies (db) from hcmv-infected cells
11/15/2012WO2012151687A1 Par1 inhibitors for use in the treatment or prevention of paramyxoviridae infections
11/15/2012WO2012151636A1 Actin binding agents
11/15/2012WO2012151609A1 Method of treatment and prophylaxis of pathologies of the bone
11/15/2012WO2012128667A3 Vaccine against transmissible gastroenteritis in pigs and method for using said vaccine
11/15/2012WO2012106363A3 Treatment of tauopathies
11/15/2012US20120289679 Novel mite allergen
11/15/2012US20120288931 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/15/2012US20120288916 Immortalized avian cell lines for virus production
11/15/2012US20120288557 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
11/15/2012US20120288554 Canfosfamide monotherapy for treating multiple myeloma
11/15/2012US20120288552 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
11/15/2012US20120288538 Vaccine against neoplastic or cancerous lesions caused by human papilloma virus (hpv), procedures, uses and methods
11/15/2012US20120288537 Active self-healing biomaterial system
11/15/2012US20120288536 Stabilized Stat3 Decoy Oligonucleotides And Uses Therefor
11/15/2012US20120288528 Mono-and disaccharide derivatives
11/15/2012US20120288527 Antiallergic agent
11/15/2012US20120288526 Dna sequence and preparation of grass pollen allergen phl p4 by recombinant methods
11/15/2012US20120288525 Pharmaceutical compositions comprising attenuated plasmodium sporozoites and glycolipid adjuvants
11/15/2012US20120288524 Leishmania-based carrier for vaccine delivery
11/15/2012US20120288523 Administration route for a composition to protect an animal against rhodococcus equi
11/15/2012US20120288522 Novel Pneumovirus Compositions and Methods For Using the Same
11/15/2012US20120288521 Multi plasmid system for the production of influenza virus
11/15/2012US20120288520 Recombinant Flavivirus Vaccines
11/15/2012US20120288518 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines
11/15/2012US20120288517 Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof
11/15/2012US20120288516 Markers of XMRV Infection And Uses Thereof
11/15/2012US20120288515 Synthetic long peptide (slp)-based vaccines
11/15/2012US20120288514 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
11/15/2012US20120288512 Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
11/15/2012US20120288511 Glucagon/glp-1 receptor co-agonists
11/15/2012US20120288510 Human antibodies against hepatitis c virus (hcv) and uses thereof
11/15/2012US20120288509 Analysis of methylated nucleic acid
11/15/2012US20120288508 Antibodies against clostridium difficile toxins and uses thereof
11/15/2012US20120288507 Wise binding agents and epitopes
11/15/2012US20120288506 C-kit antibodies and uses thereof
11/15/2012US20120288505 Gene delivery
11/15/2012US20120288504 Antagonists of il-6 to prevent or treat thrombosis
11/15/2012US20120288503 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
11/15/2012US20120288502 Compositions and methods for improving potency and breadth of hiv antibodies
11/15/2012US20120288501 Substituted benzazoles and methods of their use as inhibitors of raf kinase
11/15/2012US20120288500 Human monoclonal antibodies to btla and methods of use
11/15/2012US20120288499 Methods for diagnosis and treatment of cutaneous t cell lymphomas
11/15/2012US20120288498 Polynucleotides and polypeptide sequences involved in cancer
11/15/2012US20120288497 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer
11/15/2012US20120288496 Notch-Binding Agents and Antagonists and Methods of Use Thereof
11/15/2012US20120288495 Therapeutic compositions and methods
11/15/2012US20120288494 Anti-IL-12/IL-23 antibodies and uses thereof
11/15/2012US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof
11/15/2012US20120288492 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/15/2012US20120288491 Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
11/15/2012US20120288476 Structure and use of 5' phosphate oligonucleotides
11/15/2012US20120288475 Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure
11/15/2012US20120288473 Compositions, methods, and kits for eliciting an immune response
11/15/2012US20120288472 Regulation of t cell-mediated immunity by tryptophan
11/15/2012DE10351627B4 Modulation der Angiogenese durch Bartonella henselae Modulation of angiogenesis by Bartonella henselae
11/15/2012DE102011101446A1 Herstellung von "Dense Bodies" (DB) Production of "dense bodies" (DB)
11/15/2012CA2850576A1 Production of "dense bodies" (db) from hcmv-infected cells
11/15/2012CA2835630A1 Modified biotin-binding protein, fusion proteins thereof and applications
11/15/2012CA2835628A1 Multiple antigen presenting immunogenic composition, and methods and uses thereof
11/15/2012CA2835603A1 Antibody capable of specifically recognizing transferrin receptor
11/15/2012CA2835576A1 Protein-active agent conjugates and method for preparing the same
11/15/2012CA2835522A1 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing
11/15/2012CA2835510A1 Protein f - a novel haemophilus influenzae adhesin with laminin and vitronectin binding properties
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 1823